Mylan Inc. has launched bupropion hydrochloride extended-release tablets, indicated for the treatment of depression.


Mylan, bupropion hydrochloride extended-release tablets, Wellbutrin, Wellbutrin XL, Mylan Pharmaceuticals, generic version, antidepressant












































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Mylan ships generic version of Wellbutrin XL

October 1st, 2010

PITTSBURGH – Mylan Inc. has launched bupropion hydrochloride extended-release tablets, indicated for the treatment of depression.

The drug maker said Friday that its Mylan Pharmaceuticals Inc. subsidiary released launched bupropion hydrochloride extended-release tablets USP in 150-mg and 300-mg doses, which are taken once each day.

Mylan said the new product is the generic version of GlaxoSmithKline's antidepressant Wellbutrin XL.

Bupropion hydrochloride extended-release tablets had U.S. sales of about $752 million for the 12 months ended June 30, according to IMS Health data cited by Mylan.

Advertisement